Zealand Pharma A/S
ZLDPF
$54.00
$0.480.90%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 362.62% | 729.97% | 1,093.48% | 27,971.16% | -48.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 362.62% | 729.97% | 1,093.48% | 27,971.16% | -48.63% |
| Cost of Revenue | -- | -100.00% | -- | -95.44% | -- |
| Gross Profit | 362.62% | 769.12% | 377.51% | 38,779.12% | -26.13% |
| SG&A Expenses | 10.99% | -34.98% | 116.26% | 44.11% | 31.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.66% | 66.10% | 54.86% | 161.93% | 48.04% |
| Operating Income | -44.51% | -51.04% | -41.62% | 3,384.00% | -53.74% |
| Income Before Tax | -27.64% | -52.04% | -45.59% | 3,007.76% | -41.53% |
| Income Tax Expenses | -- | -5,106.46% | 2,999.51% | 43,140.49% | 28.34% |
| Earnings from Continuing Operations | -28.02% | -42.07% | -61.31% | 2,827.34% | -41.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.02% | -42.07% | -61.31% | 2,827.34% | -41.94% |
| EBIT | -44.51% | -51.04% | -41.62% | 3,384.00% | -53.74% |
| EBITDA | -43.60% | -51.37% | -41.94% | 3,471.63% | -55.88% |
| EPS Basic | -28.15% | -42.84% | -62.14% | 2,517.38% | -23.77% |
| Normalized Basic EPS | -15.42% | -64.65% | -42.26% | 2,596.02% | -27.52% |
| EPS Diluted | -28.15% | -42.82% | -62.14% | 2,484.19% | -23.77% |
| Normalized Diluted EPS | -15.42% | -64.65% | -42.26% | 2,561.76% | -27.52% |
| Average Basic Shares Outstanding | -0.09% | -0.54% | -0.51% | 12.83% | 14.68% |
| Average Diluted Shares Outstanding | -0.09% | -0.54% | -0.51% | 14.40% | 14.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |